Article thumbnail

Palmitate Induced IL-6 and MCP-1 Expression in Human Bladder Smooth Muscle Cells Provides a Link between Diabetes and Urinary Tract Infections

By Andreas Oberbach, Nadine Schlichting, Matthias Blüher, Peter Kovacs, Holger Till, Jens-Uwe Stolzenburg and Jochen Neuhaus
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2878332
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes.
  2. (2002). Antimicrobial treatment in diabetic women with asymptomatic bacteriuria.
  3. (1999). Atherosclerosis—an inflammatory disease.
  4. (2002). C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in nondiabetic subjects; the Insulin Resistance Atherosclerosis Study.
  5. (2004). Ceramide induces caspase-dependent and -independent apoptosis in A-431 cells.
  6. (2003). Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.
  7. (1999). Chemokines and atherosclerosis.
  8. (2008). Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes.
  9. (2006). Factor From Human Detrusor Smooth Muscle Cells: Synergy With Interleukin-1beta and Tumor Necrosis Factor-alpha.
  10. (1996). Folate and cardiovascular disease. Why we need a trial now.
  11. (2006). Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.
  12. (1999). Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.
  13. (2007). Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome.
  14. (2009). Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways.
  15. (1999). Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection.
  16. (2006). Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
  17. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
  18. (2005). Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.
  19. (2004). Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factorkappaB.
  20. (2004). Palmitateinduced interleukin-6 expression in human coronary artery endothelial cells.
  21. (2006). Pathogen recognition and innate immunity.
  22. (2003). Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus.
  23. (2003). Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells.
  24. (2008). Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.
  25. (2000). Risk factors for symptomatic urinary tract infection in women with diabetes.
  26. (2003). SOCS3 negatively regulates IL-6 signaling in vivo.
  27. (2009). Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells.
  28. (2009). The c-Jun Nterminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes.
  29. (2007). The importance of free fatty acids in the development of Type 2 diabetes.
  30. (2001). Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation.
  31. (2002). Urinary tract infections in patients with diabetes.